Patch vs. pill: new ozanimod skin patch tested in healthy volunteers
NCT ID NCT06528665
First seen Feb 27, 2026 · Last updated May 22, 2026 · Updated 15 times
Summary
This study tested a new skin patch (transdermal delivery system) for the drug ozanimod, which is used to treat multiple sclerosis and ulcerative colitis. Researchers wanted to see how well the drug is absorbed through the skin compared to taking it as an oral capsule. Twenty-four healthy adults either took one capsule or wore a patch for 7 days, and blood samples were taken to measure drug levels. The study focused on safety, tolerability, and how the drug moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Ampang
Ampang, Selangor, 68000, Malaysia
Conditions
Explore the condition pages connected to this study.